Acionna Therapeutics

Acionna Therapeutics develops novel treatments targeting the neuroimmune cascade to enhance synaptic function, focusing on neurodegenerative diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

Acionna Therapeutics develops novel treatments targeting the neuroimmune cascade to enhance synaptic function, focusing on neurodegenerative diseases.

02Backed By1 investor

OSOxford Science Enterprises→

03Similar Companies

NB

Is this your company? Claim your profile

Nura Bio

Biotech & Life Sciences

→

TT

Tranquis Therapeutics

Biotech & Life Sciences

→

AL

AstronauTX Ltd

Biotech & Life Sciences

→

RP

Reata Pharmaceuticals

Biotech & Life Sciences

→

LT

Leal Therapeutics

Biotech & Life Sciences

→

04Startup DNA

7

signals

Sectors
Business Model
Technology